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INTRODUCTION
Macular pigment (MP), which is composed of three dietary carotenoids,
lutein (L), zeaxanthin (Z) and meso-zeaxanthin (MZ), is predominantly
located at the site of maximum visual acuity in the human retina. MP
absorbs short wavelength light prior to photoreceptor stimulation. Filtering
such defocused short wavelength (blue) light could enhance visual
performance by reducing the effects of chromatic aberration and light
scatter.1 This hypothesis, in relation to MP, remains unproven and poorly
investigated to date.
Figure 1.
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Contrast sensitivity function (CSF)
Mesopic (3 cd/m2) and photopic (100cd/m2) CSF curves were plotted using
spatial frequencies of 1 cycle per degree (cpd), 4.1 cpd, 7.5 cpd, 11.8 cpd
and 20.7 cpd. Gabor stimuli were displayed on a CRT monitor and
sensitivities were determined using a linear staircase procedure.

Glare sensitivity
Mesopic (3 cd/m2) and photopic (85 cd/m2) contrast sensitivity was also
tested under glare conditions using a sine grating functional acuity contrast
test, and a radial glare source. CSF curves were plotted using spatial
frequencies of 1.5 cpd, 3 cpd, 6 cpd, 12 cpd and 18 cpd. Glare effects on
the CSF were determined for medium (35 Lux) and high (128 Lux) glare
intensities.

There was an inverse relationship between mesopic contrast sensitivity
under glare conditions for all spatial frequencies and MPOD at all
degrees of retinal eccentricity, but was not statistically significant (p >
0.05).

Photostress Recovery Time (PRT)
PRT was evaluated using a previously described macular automated
photostress test4 using a Humphrey 745 visual field analyzer.
Central, pre-receptoral retinal location of MP. Adapted from
Trieschmann et al., 20082

PURPOSE
The Collaborative Optical Macular Pigment ASsessment Study
(COMPASS) is a double blind, placebo controlled and randomized clinical
trial, designed to investigate whether MP optical density (MPOD)
influences spatial vision and visual comfort by means of selective short
wavelength light absorption prior to photoreceptor light capture.

SUBJECTS and METHODS

RESULTS
These results represent the baseline findings from COMPASS. Mean ± SD
MPOD obtained at peak (0.25º eccentricity) was 0.48 ± 0.19. There was a
statistically significant positive relationship between BCVA and MPOD at all
retinal eccentricities (r = 0.236 to 0.354, p < 0.01) [Figures 2 and Figure 3
illustrate the relationship at 0.25º and 0.50º respectively].
Figure 2.

Figure 3.

We recruited 142 young healthy subjects (mean ± SD age = 28.85 ± 6.37
years). The spatial profile of MPOD was assessed by customized
heterochromatic flicker photometry (cHFP), which has been shown to be
a reliable and repeatable method of quantifying MPOD.3 Visual
performance was assessed using visual acuity, mesopic and photopic
contrast sensitivity, glare sensitivity and photostress recovery time
measures. Each subject also completed a visual performance
questionnaire, generating a performance index of the subject’s perception
of their functional vision in terms of colour, acuity, glare, light/dark
adaptation and daily visual tasks.

MPOD measurement
MPOD measurements were obtained by cHFP (using the Macular
DensitometerTM) at five loci (0.25º, 0.50º, 1º, 1.75º and 3º of retinal
eccentricity), with a reference point at 7º, to generate a complete spatial
profile of MP.

Best corrected visual acuity (BCVA)
BCVA was assessed using a computer-generated LogMAR, high contrast
chart, employing a SLOAN ETDRS letterset. A visual acuity rating (VAR)
was computed to quantify precise acuity limits.

There was no statistically significant relationship observed between
MPOD and any of the functional aspects of subjective visual function
questionnaire (r = -0.188 to 0.148, p > 0.05). There was also no
statistically significant relationship observed between MPOD and PRT.
(r = 0.002 to 0.102, p > 0.05).

CONCLUSION
Given its short wavelength absorption characteristics and central,
prereceptorial location [see Figure 1], MP exhibits ideal properties to
optimize visual performance. Visual performance, as assessed by visual
acuity and contrast sensitivity measures, does appear to be influenced by
MPOD. Photostress recovery and visual performance under glare conditions
however show no significant relationship with MPOD.
The lack of consistency among the results possibly reflects the inherent
difficulty associated with efforts to clarify the role of MP with respect to visual
performance using a cross sectional methodology. A placebo controlled,
randomized MP supplementation clinical trial, has the capacity to more
adequately address the critical research question.
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